Obstetrics and Gynecology

1046 questions

Question 261Question →

A 31-year-old G2P1 woman at 39 weeks gestation is admitted to the labor and delivery unit in active labor. Her most recent cervical examination shows 5 cm dilation, 80% effacement, and the fetal vertex at -2 station. Shortly after admission, the patient experiences spontaneous rupture of membranes with a large gush of clear amniotic fluid. Immediately following this event, the continuous fetal heart rate monitor demonstrates a sudden, prolonged deceleration, with the heart rate dropping to 60/min and remaining there. A prompt sterile vaginal examination is performed, which reveals a pulsating, rope-like structure palpable in the vaginal canal ahead of the fetal presenting part. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Manually elevate the fetal presenting part and prepare for emergency cesarean delivery

Answer

Manually elevate the fetal presenting part and prepare for emergency cesarean delivery
The clinical presentation of a sudden, prolonged fetal heart rate deceleration following rupture of membranes, combined with a palpable pulsating mass in the vagina, is diagnostic of umbilical cord prolapse. This is an acute obstetric emergency where the umbilical cord descends ahead of the fetal presenting part, leading to severe compression of the cord vessels between the fetus and the maternal pelvis. The most appropriate immediate management is to manually elevate the fetal presenting part off the prolapsed cord to restore fetal blood flow while simultaneously preparing for an emergent cesarean delivery.

Step-by-Step Solution

1
Identify the primary clinical diagnosis based on the physical exam findings.
The patient has an overt umbilical cord prolapse, evidenced by the palpable pulsating cord in the vagina following rupture of membranes.
Accurate diagnosis is required to triage the severity of the fetal bradycardia.
2
Determine the pathophysiologic consequence of the diagnosis.
The fetal head is compressing the prolapsed umbilical cord against the maternal pelvis, leading to absent blood flow and profound fetal hypoxia.
Understanding the mechanism of hypoxia dictates the required mechanical intervention.
3
Select the most appropriate definitive management.
The immediate priority is to physically lift the fetal head off the cord to restore perfusion, followed by rapid surgical delivery.
Prompt relief of compression is necessary to prevent permanent fetal neurologic injury or death.

Key Concept

The management of an overt umbilical cord prolapse requires immediate manual elevation of the fetal presenting part to relieve cord compression, followed by an emergent cesarean delivery.
Question 262Question →

Match each gestational age window or prenatal visit timing with the most appropriate routine screening test indicated at that time for an average-risk, uncomplicated pregnancy.

Click a left item, then click its matching right item

Items

Initial prenatal visit (First Trimester)
15 to 22 weeks gestation
24 to 28 weeks gestation
35 to 37 weeks gestation

Matches

Show answer & explanation

Answer

The initial visit matches with ABO/Rh typing; 15-22 weeks matches with the MSAFP/Quad screen; 24-28 weeks matches with the 1-hour glucose challenge test; and 35-37 weeks matches with the GBS rectovaginal culture.
Each routine prenatal screening test has a rigorously defined optimal window based on fetal development, maternal physiological adaptations (like insulin resistance), and the temporal proximity required for safe delivery management.

Step-by-Step Solution

1
Determine the required baseline laboratory tests for early pregnancy.
The initial prenatal visit (first trimester) includes checking ABO blood type and Rh(D) status to plan for potential anti-D immune globulin administration.
Early identification of Rh-negative mothers is critical to prevent hemolytic disease of the fetus and newborn.
2
Identify the screening window for structural and genetic abnormalities.
The 15 to 22-week window is appropriate for the quadruple marker screen (including MSAFP).
Analyte levels during this specific gestational timeframe offer the highest sensitivity for detecting open neural tube defects and common aneuploidies.
3
Identify when maternal metabolic changes necessitate diabetes screening.
The 24 to 28-week window corresponds to the 1-hour 50-g oral glucose challenge test.
Placental hormones, primarily human placental lactogen, increase insulin resistance significantly by late second trimester, making this the optimal time to detect gestational diabetes.
4
Determine the timing for infectious disease screening related to delivery.
The 35 to 37-week window requires rectovaginal screening for Group B Streptococcus.
Because GBS flora can change over time, testing must occur within 5 weeks of expected delivery to accurately guide intrapartum prophylaxis.

Key Concept

Routine Prenatal Screening Schedule
Question 263Question →

Match each obstetric patient presentation with the most appropriate indicated management or screening plan.

Click a left item, then click its matching right item

Items

10 weeks gestation; prior pregnancy with trisomy 13; desires the most accurate non-invasive screening.
18 weeks gestation; BMI 40 kg/m²; missed first-trimester screening; desires comprehensive aneuploidy and neural tube defect screening.
28 weeks gestation; Rh(D)-negative; presents with acute mild vaginal bleeding; initial antibody screen is negative.
36 weeks gestation; asymptomatic today; treated for a Group B Streptococcus (GBS) urinary tract infection at 12 weeks gestation.
38 weeks gestation; HIV-positive on combined antiretroviral therapy; maternal viral load is currently 20 copies/mL.

Matches

Show answer & explanation

Answer

The correct matches align each unique clinical presentation with its specific guideline-based management, focusing on exceptions to routine prenatal care such as alternative screening for obese patients, quantitative testing for Rh-negative patients with bleeding, and omitting unnecessary screening in patients already indicated for prophylaxis.
Each presentation represents a specific nuance or exception within standard normal prenatal care guidelines. Accurately managing these edge cases requires understanding the limitations of screening modalities (e.g., cffDNA in high BMI), indications for quantitative fetomaternal hemorrhage testing, and specific thresholds for intrapartum prophylaxis.

Step-by-Step Solution

1
Evaluate the 10-week gestation patient with prior trisomy 13.
Match with cffDNA testing.
cffDNA is the most accurate non-invasive screening for aneuploidy and can be performed from 10 weeks onward.
2
Evaluate the 18-week gestation obese patient who missed early screening.
Match with quadruple screen and anatomy ultrasound.
She requires both aneuploidy and NTD screening. cffDNA does not test for NTDs and has a high failure rate in severe obesity.
3
Evaluate the 28-week Rh-negative patient with vaginal bleeding.
Match with standard anti-D immune globulin and Kleihauer-Betke test.
While routine 28-week prophylaxis is needed, bleeding introduces risk of excessive fetomaternal hemorrhage requiring quantification.
4
Evaluate the 36-week patient with prior GBS bacteriuria.
Match with omitting the screening culture and planning intrapartum prophylaxis.
GBS bacteriuria indicates heavy colonization, automatically qualifying her for antibiotics and making the swab redundant.
5
Evaluate the 38-week HIV-positive patient with undetectable viral load.
Match with trial of labor without intrapartum IV zidovudine.
Viral load < 1,000 permits vaginal delivery, and < 50 eliminates the need for intrapartum IV zidovudine.

Key Concept

Nuanced applications of routine prenatal screening and prophylactic guidelines.
Question 264Question →

A 26-year-old G1P0 woman at 39 weeks gestation is evaluated in the labor and delivery unit for active labor. Her pregnancy has been uncomplicated. Her membranes spontaneously ruptured 4 hours ago, yielding clear fluid. Her temperature is 37.1°C (98.8°F), blood pressure is 120/78 mm Hg, and pulse is 88/min. Laboratory studies show a hemoglobin concentration of 10.5 g/dL. The cervix is 7 cm dilated, 100% effaced, and the fetal vertex is at 0 station. Uterine contractions occur every 3 minutes and are of moderate intensity. Fetal heart rate monitoring demonstrates a baseline of 140/min with moderate variability. Over the last 45 minutes, there are recurrent, abrupt decreases in the fetal heart rate to 80-90/min, lasting for 45-60 seconds, which occur with approximately 60% of the contractions. The decelerations rapidly return to the baseline. Maternal repositioning to the left lateral decubitus position, administration of oxygen, and an intravenous fluid bolus are performed, but the fetal heart rate pattern remains unchanged over the next 15 minutes. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Amnioinfusion

Answer

Amnioinfusion
The correct answer is amnioinfusion. This patient's fetal heart rate monitoring demonstrates recurrent variable decelerations, which are defined as abrupt decreases in the fetal heart rate (onset to nadir in less than 30 seconds) that drop at least 15 beats per minute below baseline for at least 15 seconds. They are caused by umbilical cord compression, which is particularly common after the rupture of membranes (as seen in this patient) due to the loss of amniotic fluid cushioning. Initial management of recurrent variable decelerations involves noninvasive intrauterine resuscitation, including maternal repositioning, intravenous fluid administration, and supplemental oxygen. If the decelerations persist despite these initial measures, the next appropriate step is an amnioinfusion. This procedure involves instilling an isotonic fluid (such as normal saline) through an intrauterine pressure catheter into the amniotic cavity. The added fluid restores the amniotic cushion, relieves the compression on the umbilical cord, and often resolves the decelerations, potentially avoiding an unnecessary surgical delivery.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) description.
The FHR shows abrupt decreases to 80-90/min that quickly return to baseline.
Abrupt decreases in FHR characterize variable decelerations, which are typically caused by umbilical cord compression.
2
Evaluate the current management status.
Initial intrauterine resuscitation (maternal repositioning, oxygen, IV fluids) has already been performed without success.
Variable decelerations are first managed with noninvasive maneuvers. If these fail, escalated intervention is required.
3
Determine the next best step for refractory variable decelerations.
Amnioinfusion is indicated.
Instilling saline into the amniotic cavity relieves umbilical cord compression and often resolves variable decelerations, potentially averting the need for a cesarean delivery.

Key Concept

Recurrent variable decelerations are caused by umbilical cord compression. If initial intrauterine resuscitation measures fail, the next step in management is amnioinfusion.
Question 265Question →

A 45-year-old woman, gravida 3, para 3, comes to the clinic complaining of involuntary urine leakage for the past 4 months. She states that the leakage typically occurs when she coughs, sneezes, or laughs heartily. She does not experience a sudden, overwhelming urge to urinate prior to the leakage and does not wake up at night to void. Her medical history is unremarkable, and she had three uncomplicated vaginal deliveries. Physical examination reveals a positive cough stress test with leakage of urine from the urethra. Urinalysis is normal, and postvoid residual volume is 25 mL. Which of the following is the most appropriate initial management for this patient?

Show answer & explanation

Answer: Pelvic floor muscle exercises

Answer

Pelvic floor muscle exercises
This patient's presentation of urine leakage exclusively during activities that increase intra-abdominal pressure (coughing, sneezing, laughing), absent sudden urge, and normal postvoid residual is classic for stress urinary incontinence. The pathophysiology involves urethral hypermobility and/or intrinsic sphincter deficiency, often related to multiparity. The most appropriate initial, non-invasive management for stress urinary incontinence is strengthening the pelvic floor musculature (Kegel exercises) to improve active urethral support.

Step-by-Step Solution

1
Analyze the patient's symptoms and triggers for urine leakage.
Leakage occurs only with coughing, sneezing, and laughing (increased intra-abdominal pressure), without a sudden urge to void.
Identifying the trigger is crucial for diagnosing the specific type of urinary incontinence.
2
Interpret the physical exam and diagnostic findings.
Positive cough stress test, normal urinalysis (rules out infection), and normal postvoid residual (rules out overflow incontinence).
Confirms the diagnosis of stress urinary incontinence and excludes other causes of leakage.
3
Determine the most appropriate initial management for stress urinary incontinence.
Conservative management with pelvic floor muscle exercises is indicated as the first-line therapy.
Non-invasive interventions should be trialed before considering invasive surgical procedures like a midurethral sling.

Key Concept

Diagnosis and initial management of stress urinary incontinence
Question 266Question →

A 64-year-old woman, G2P2, comes to the office due to a 2-week history of vaginal bleeding. She describes the bleeding as spotting that occasionally requires a panty liner. Her last menstrual period was 12 years ago, and she did not receive hormone replacement therapy. She has a medical history of obesity, essential hypertension, and type 2 diabetes mellitus. Her current medications include lisinopril and metformin. Vital signs are within normal limits. Pelvic examination shows a normal-appearing vagina and cervix with no visible lesions. A small amount of dark blood is noted in the posterior vaginal fornix. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
The correct answer is endometrial biopsy. Any episode of postmenopausal bleeding must be considered a potential sign of endometrial carcinoma until proven otherwise. This patient has multiple risk factors for endometrial cancer, including advanced age, obesity, and type 2 diabetes (which contributes to hyperestrogenism through the peripheral conversion of androgens to estrogens in adipose tissue). Endometrial sampling is the most appropriate and definitive diagnostic step to rule out malignancy. A transvaginal ultrasound is an acceptable alternative first step (to measure endometrial thickness), but among the choices provided, endometrial biopsy is the definitive next step in management.

Step-by-Step Solution

1
Identify the primary clinical presentation.
The patient is a 64-year-old postmenopausal woman presenting with new-onset vaginal bleeding.
Recognizing postmenopausal bleeding is critical as it is a major red flag symptom.
2
Assess the patient's risk factors.
The patient has advanced age, obesity, and type 2 diabetes mellitus, which are significant risk factors for endometrial cancer.
Obesity and diabetes contribute to a hyperestrogenic state through peripheral conversion of androgens, increasing the risk of endometrial hyperplasia and carcinoma.
3
Determine the required diagnostic evaluation.
Tissue sampling of the endometrium is required to rule out malignancy.
Postmenopausal bleeding requires prompt histologic evaluation (endometrial biopsy) or structural evaluation (transvaginal ultrasound showing a stripe >4 mm) to exclude endometrial cancer.

Key Concept

Any postmenopausal bleeding requires prompt evaluation with an endometrial biopsy (or transvaginal ultrasound) to rule out endometrial carcinoma, especially in patients with risk factors like obesity and diabetes.
Question 267Question →

A 62-year-old woman comes to the office due to a 3-week history of episodic vaginal bleeding. She reached menopause at age 52 and has not had any vaginal bleeding since then. Her medical history is significant for obesity, type 2 diabetes mellitus, and hypertension. Current medications include metformin and lisinopril. Her body mass index (BMI) is 34 kg/m². Pelvic examination shows normal external genitalia and a nulliparous cervix without visible lesions. Bimanual examination reveals a normal-sized, mobile uterus with no adnexal masses. A transvaginal ultrasound is performed and shows an endometrial stripe thickness of 7 mm. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

The most appropriate next step in management is to perform an endometrial biopsy.
The correct answer is endometrial biopsy. The patient presents with postmenopausal bleeding and an endometrial stripe of 7 mm (which is > 4 mm). This presentation is highly suspicious for endometrial hyperplasia or cancer, particularly given her prominent risk factors of obesity, nulliparity, and type 2 diabetes. Tissue diagnosis via an office endometrial biopsy is mandatory to definitively rule out malignancy.

Step-by-Step Solution

1
Identify the patient's primary presenting symptom and menopausal status.
The patient is a 62-year-old postmenopausal woman with a new onset of abnormal vaginal bleeding.
Postmenopausal bleeding is a major red flag symptom for endometrial carcinoma and requires immediate, thorough evaluation.
2
Evaluate the patient's risk factors for endometrial cancer.
The patient has multiple significant risk factors, including advanced age, obesity, type 2 diabetes, nulliparity, and unopposed estrogen exposure due to peripheral conversion of androgens in adipose tissue.
Recognizing risk factors increases the clinical index of suspicion for an underlying malignancy.
3
Interpret the transvaginal ultrasound (TVUS) findings.
The TVUS shows an endometrial stripe of 7 mm.
An endometrial thickness strictly > 4 mm in a postmenopausal woman is considered abnormal and highly concerning for endometrial hyperplasia or cancer.
4
Determine the next best step in clinical management.
Endometrial biopsy.
Tissue sampling is the gold standard and a mandatory diagnostic step to rule out endometrial adenocarcinoma in the setting of postmenopausal bleeding with a thickened endometrium.

Key Concept

Any postmenopausal woman presenting with vaginal bleeding and an endometrial stripe thickness strictly greater than 4 mm requires an endometrial biopsy to rule out endometrial carcinoma.
Question 268Question →

A 24-year-old woman comes to the clinic because she has not had a menstrual period for the past 3 months. Menarche occurred at age 12, and her menses had previously occurred at regular 28-day intervals. She has no other symptoms such as headaches, visual changes, or nipple discharge. She takes no daily medications and has no chronic medical conditions. She is sexually active with a male partner and relies on the withdrawal method for contraception. Vital signs include a temperature of 37.0°C (98.6°F), blood pressure of 118/76 mm Hg, pulse of 74/min, and BMI of 23 kg/m². Physical examination shows normal breast development, no hirsutism or acne, and a normal pelvic examination. Which of the following is the most appropriate initial step in evaluating this patient's condition?

Show answer & explanation

Answer: Measurement of serum human chorionic gonadotropin

Answer

Measurement of serum human chorionic gonadotropin
The patient meets the criteria for secondary amenorrhea, defined as the absence of menses for 3 or more months in a woman who previously had regular menstrual cycles. In any woman of reproductive age presenting with amenorrhea, the most common cause is pregnancy. Even with reported contraceptive use (especially unreliable methods like withdrawal), a pregnancy test (serum or urine beta-hCG) is the mandatory initial step. Only after pregnancy is ruled out should the physician proceed to evaluate other causes, such as thyroid dysfunction, hyperprolactinemia, or hypothalamic-pituitary-ovarian axis disorders.

Step-by-Step Solution

1
Identify the patient's primary presentation
The patient has secondary amenorrhea (absence of menses for ≥3 months in a woman with previously regular cycles).
Establishing the clinical definition guides the standardized diagnostic algorithm.
2
Determine the most common etiology
Pregnancy is the most common cause of secondary amenorrhea in women of reproductive age.
The withdrawal method of contraception has a high typical-use failure rate, increasing the probability of pregnancy in this sexually active patient.
3
Select the initial diagnostic test based on the etiology
A urine or serum beta-human chorionic gonadotropin (beta-hCG) test is required.
Pregnancy must be definitively ruled out before pursuing further endocrine, imaging, or pharmacological workup to avoid fetal harm and unnecessary testing.

Key Concept

The initial step in the evaluation of secondary amenorrhea in any woman of reproductive age is a pregnancy test (measurement of beta-hCG).
Question 269Question →

A 64-year-old woman, gravida 0, presents to the clinic reporting a two-week history of intermittent vaginal spotting. She reached menopause at age 52. Past medical history includes type 2 diabetes mellitus, chronic hypertension, and obesity. Her body mass index is 38 kg/m². Pelvic examination reveals a small amount of dark blood in the vaginal vault. The cervix appears grossly normal, and the uterus is non-tender and mobile. A transvaginal ultrasound shows an endometrial thickness of 9 mm. An office endometrial biopsy is performed; however, the pathology report returns as 'scant cellular material, composed primarily of blood and mucus, insufficient for diagnosis.' Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Hysteroscopy with dilation and curettage

Answer

Hysteroscopy with dilation and curettage is the most appropriate next step in management.
The correct response recommends hysteroscopy with dilation and curettage. Any postmenopausal bleeding requires prompt evaluation for endometrial cancer. The initial step is often a transvaginal ultrasound; an endometrial thickness >4 mm mandates tissue sampling. While an office endometrial biopsy is the preferred initial sampling method due to its low cost and risk, it has a failure rate. When the pathology returns as 'insufficient tissue' in a patient with a thickened endometrium, malignancy has not been ruled out. The clinician must proceed to a more definitive sampling procedure, which is hysteroscopy with directed biopsy and dilation and curettage (D&C).

Step-by-Step Solution

1
Analyze the patient's risk profile and presentation.
The patient is a 64-year-old postmenopausal woman with abnormal uterine bleeding, obesity, nulliparity, and diabetes.
These factors place her at high risk for endometrial hyperplasia and adenocarcinoma due to prolonged unopposed estrogen exposure.
2
Evaluate the initial diagnostic workup.
Transvaginal ultrasound revealed a thickened endometrial stripe (9 mm), prompting an office endometrial biopsy, which returned with insufficient tissue.
An endometrial thickness greater than 4 mm in a postmenopausal woman requires histologic evaluation to rule out malignancy.
3
Determine the next best step based on the non-diagnostic biopsy result.
Hysteroscopy with dilation and curettage must be performed.
An 'insufficient' biopsy does not mean the endometrium is normal; it simply means the sample was inadequate. Definitive evaluation requires a more invasive sampling method.

Key Concept

Postmenopausal bleeding with an endometrial stripe >4 mm requires definitive histologic evaluation. If an office endometrial biopsy yields insufficient tissue, a hysteroscopy with dilation and curettage is mandated to definitively rule out endometrial carcinoma.
Question 270Question →

A 6464-year-old woman, G2P2, comes to the office due to a 33-month history of intermittent vaginal bleeding and new-onset breast fullness. Menopause occurred at age 5252. She has no other medical conditions and takes no medications. Vital signs are within normal limits. Pelvic examination reveals a normal-appearing vagina and cervix. Bimanual examination demonstrates a mobile, 88-cm, solid mass in the right adnexa and a globally enlarged, soft uterus. Transvaginal ultrasonography shows an 88-cm right ovarian mass with solid and cystic components, and an endometrial stripe thickness of 1414 mm. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
The correct next best step is an office endometrial biopsy. This patient presents with classic signs of hyperestrogenism: postmenopausal bleeding, breast fullness, a thickened endometrial stripe (1414 mm), and a solid/cystic adnexal mass. This presentation is highly suspicious for a granulosa cell tumor, an estrogen-secreting sex cord-stromal ovarian neoplasm. Chronic, unopposed estrogen exposure frequently leads to concurrent endometrial hyperplasia (up to 50%50\% of cases) or endometrial adenocarcinoma (5%5\% to 10%10\% of cases). While the ovarian mass will ultimately require surgical excision and staging, the immediate priority is to obtain a tissue diagnosis of the endometrium. If concurrent endometrial cancer is identified, the planned surgical procedure must be expanded to include complete staging for both malignancies (e.g., pelvic and para-aortic lymphadenectomy), which might not be routinely performed for an isolated presumed early-stage granulosa cell tumor. Therefore, histologic evaluation via a simple, minimally invasive office endometrial biopsy must precede definitive surgery.

Step-by-Step Solution

1
Identify the primary clinical abnormalities from the vignette.
The patient has postmenopausal bleeding (PMB), new breast fullness, an 88-cm complex adnexal mass, and a significantly thickened endometrium (1414 mm).
Recognizing these key findings is necessary to formulate a differential diagnosis and management plan.
2
Synthesize the findings to suspect a specific underlying pathology.
The combination of an adnexal mass, PMB, breast fullness, and endometrial thickening strongly points to a hormonally active tumor, specifically an estrogen-secreting granulosa cell tumor of the ovary.
Unregulated estrogen stimulation causes endometrial proliferation, leading to hyperplasia or carcinoma, and breast tenderness.
3
Determine the priority of management algorithms.
Although the adnexal mass requires surgical removal, the PMB with an endometrial stripe >4>4 mm mandates an immediate histologic evaluation of the endometrium.
Preoperative knowledge of endometrial pathology (hyperplasia vs. carcinoma) is essential, as the presence of endometrial cancer requires a more extensive surgical staging procedure (e.g., lymph node dissection) than the ovarian mass alone might dictate.
4
Select the most appropriate initial diagnostic modality.
An office endometrial biopsy is the highly sensitive, cost-effective, and minimally invasive first step.
It avoids unnecessary immediate operative procedures like D&C while providing the necessary tissue diagnosis.

Key Concept

Evaluation of postmenopausal bleeding in the setting of a suspected estrogen-secreting adnexal mass
Question 271Question →

A 28-year-old woman, nulligravida, comes to the clinic reporting an absence of menstruation for the past 6 months. Prior to this, her menstrual cycles were regular, occurring every 28 to 30 days. Over the same 6-month period, she has noticed rapid growth of coarse, dark hair on her upper lip, chin, and lower abdomen. She also reports that her voice has deepened, and she has experienced thinning of the hair on her scalp. She has no significant past medical history and takes no medications. Her body mass index (BMI) is 22 kg/m². Vital signs are within normal limits. Physical examination reveals temporal balding and significant facial hirsutism. Pelvic examination demonstrates a normal-sized, mobile uterus and distinct clitoromegaly. A urine pregnancy test is negative. Which of the following is the most appropriate next step in diagnosis?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate levels

Answer

The correct answer is the measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEA-S) levels.
The patient's presentation of secondary amenorrhea accompanied by rapid-onset clitoromegaly, voice deepening, and temporal balding indicates frank virilization. Unlike simple hirsutism, which is often seen in benign conditions like Polycystic Ovary Syndrome (PCOS), rapid-onset virilization is a major red flag for an androgen-secreting tumor. To localize the tumor, the first step is biochemical testing with serum testosterone (produced primarily by the ovaries) and dehydroepiandrosterone sulfate (DHEA-S, produced exclusively by the adrenal glands). Elevated testosterone points to an ovarian source, while elevated DHEA-S points to an adrenal source.

Step-by-Step Solution

1
Analyze the clinical presentation.
The patient has secondary amenorrhea combined with rapid-onset signs of severe hyperandrogenism, specifically virilization (deepening voice, temporal balding, clitoromegaly).
Differentiating between simple hirsutism (gradual onset, mild androgen excess) and virilization (rapid onset, severe androgen excess) is critical for determining the etiology.
2
Formulate a differential diagnosis for virilization.
Rapid-onset virilization is highly suspicious for an androgen-secreting neoplasm of either ovarian or adrenal origin.
Unlike PCOS or NCCAH which cause gradual, mild-to-moderate hyperandrogenism, tumors secrete massive amounts of androgens rapidly.
3
Select the appropriate diagnostic workup.
Serum testosterone and DHEA-S levels must be measured to localize the source of the androgens.
Markedly elevated testosterone (>150 ng/dL) points to an ovarian tumor, prompting a pelvic ultrasound. Markedly elevated DHEA-S (>700 mcg/dL) points to an adrenal tumor, prompting an adrenal CT scan.

Key Concept

Evaluation of rapid-onset virilization and androgen-secreting tumors
Estimated Time:1m 30s
Question 272Question →

A 26-year-old woman presents to the clinic requesting emergency contraception. She reports having condomless vaginal intercourse 115 hours ago. Her last menstrual period began 16 days ago, and she usually has regular 28-day cycles. Her past medical history is significant for Wilson disease, which is well-controlled on oral D-penicillamine. She takes no other medications. She states she would also like to initiate a highly effective, long-acting reversible contraceptive method today to prevent future unintended pregnancies.

Vital signs include a blood pressure of 118/76 mmHg, a heart rate of 78/min, and a respiratory rate of 14/min. Her body mass index (BMI) is 34 kg/m234 \text{ kg/m}^2. Physical examination reveals a normal thyroid gland, clear lungs, and a soft, non-tender abdomen. Neurologic examination is unremarkable, with no resting tremor or ataxia. A urine pregnancy test obtained in the clinic is negative.

Which of the following is the most appropriate emergency contraceptive method for this patient?

Show answer & explanation

Answer: 52-mg levonorgestrel-releasing intrauterine device

Answer

The 52-mg levonorgestrel-releasing intrauterine device is the most appropriate choice.
The patient requires emergency contraception (EC) 115 hours after unprotected intercourse. She has a BMI of 34 kg/m234 \text{ kg/m}^2, is likely post-ovulation (Day 16 of a 28-day cycle), has Wilson disease, and desires long-acting reversible contraception (LARC). The 52-mg levonorgestrel-releasing intrauterine device (LNG-IUD) is highly effective for EC if placed within 120 hours (5 days) of unprotected intercourse. Unlike oral EC methods, the efficacy of the LNG-IUD is not reduced in patients with obesity, and it remains effective even if ovulation has already occurred. Furthermore, the patient has Wilson disease, which is a disorder of copper metabolism and represents an absolute contraindication (Category 4) to the Copper IUD. The 52-mg LNG-IUD perfectly meets all clinical constraints and immediately initiates her desired LARC.

Step-by-Step Solution

1
Evaluate the timeframe from unprotected intercourse to presentation.
115 hours have elapsed.
To determine which emergency contraception methods remain effective; levonorgestrel pills are best within 72 hours, while ulipristal and intrauterine devices (IUDs) are effective up to 120 hours.
2
Assess the impact of the patient's BMI on contraceptive efficacy.
The patient has a BMI of 34 kg/m234 \text{ kg/m}^2.
Obesity significantly decreases the efficacy of oral emergency contraceptives (ulipristal and levonorgestrel), making IUDs the preferred choice for reliable pregnancy prevention.
3
Consider the patient's cycle timing.
Presentation is on Day 16 of a regular 28-day cycle.
Oral emergency contraceptives act primarily by delaying ovulation and are ineffective if ovulation has already occurred. IUDs prevent fertilization and implantation, remaining highly effective.
4
Cross-reference chosen methods with patient's medical history using Medical Eligibility Criteria.
Wilson disease is present.
Wilson disease is a Category 4 absolute contraindication to the Copper IUD, leaving the 52-mg levonorgestrel-releasing IUD as the optimal choice that also provides her requested long-acting reversible contraception.

Key Concept

Selection of emergency contraception based on timeframe, BMI, cycle timing, and medical contraindications (WHO Medical Eligibility Criteria).
Estimated Time:2m 0s
Question 273Question →

A 2828-year-old G1P0 at 3939 weeks gestation is evaluated in the labor and delivery unit. At 10:00 AM10:00\text{ AM}, her cervical examination reveals 6 cm6\text{ cm} dilation, 100%100\% effacement, and the fetal head at 00 station. Artificial rupture of membranes is performed, yielding clear fluid. Due to a previous period of slow cervical change, an intrauterine pressure catheter (IUPC) is placed and an intravenous oxytocin infusion is started.

By 2:00 PM2:00\text{ PM} (44 hours later), her cervical examination remains completely unchanged at 6 cm6\text{ cm} dilation, 100%100\% effacement, and 00 station. Review of the IUPC tracing over the last hour shows 55 contractions per 1010 minutes. The contractions have peak pressures of 65 mm Hg65\text{ mm Hg} and a resting tone of 15 mm Hg15\text{ mm Hg}. The fetal heart rate tracing shows a baseline of 140/min140\text{/min}, moderate variability, and no decelerations. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Cesarean delivery

Answer

Cesarean delivery
The correct answer is cesarean delivery. This patient meets the diagnostic criteria for active phase arrest. According to ACOG guidelines, active phase arrest in the first stage of labor is defined as a maternal cervix dilated to ≥6 cm\geq 6\text{ cm} with ruptured membranes, and no cervical change for either ≥4\geq 4 hours with adequate contractions (>200>200 Montevideo units) or ≥6\geq 6 hours with inadequate contractions. This patient's Montevideo units are calculated by subtracting the resting tone (15 mm Hg15\text{ mm Hg}) from the peak pressure (65 mm Hg65\text{ mm Hg}) to get the amplitude (50 mm Hg50\text{ mm Hg}), and multiplying by the number of contractions in 1010 minutes (55). This yields 250 MVUs250\text{ MVUs}, which is adequate. Because she has had adequate contractions for 44 hours with no cervical change, she has active phase arrest and requires a cesarean delivery.

Step-by-Step Solution

1
Calculate the Montevideo units (MVUs) to determine contraction adequacy.
Amplitude = Peak (65 mm Hg65\text{ mm Hg}) - Resting tone (15 mm Hg15\text{ mm Hg}) = 50 mm Hg50\text{ mm Hg}. With 55 contractions per 1010 minutes, total MVUs = 5×50=250 MVUs5 \times 50 = 250\text{ MVUs}.
Accurate assessment of labor progression requires knowing if contractions are adequate (>200 MVUs>200\text{ MVUs}).
2
Evaluate the patient's labor progress against ACOG diagnostic criteria for active phase arrest.
The patient is at ≥6 cm\geq 6\text{ cm} dilation with ruptured membranes. She has had no cervical change for 44 hours despite adequate contractions (250 MVUs250\text{ MVUs}).
Active phase arrest criteria distinguish between patients who need more time or oxytocin and those who require surgical intervention.
3
Determine the definitive management for active phase arrest.
Cesarean delivery is indicated.
Once active phase arrest is diagnosed, further expectant management or uterotonic administration is futile and increases maternal and fetal morbidity.

Key Concept

Active phase arrest in the first stage of labor is diagnosed at ≥6 cm\geq 6\text{ cm} dilation with ruptured membranes and no cervical change for ≥4\geq 4 hours with adequate contractions (>200 MVUs>200\text{ MVUs}) or ≥6\geq 6 hours with inadequate contractions.
Question 274Question →

A 2121-year-old woman is brought to the emergency department with a 33-day history of progressively worsening lower abdominal pain, high fevers, and multiple episodes of vomiting. She is unable to keep any oral fluids down. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 98/6098/60 mmHg, and pulse is 112112/min. She is sexually active with a new partner and does not use contraception. Arrange the following steps in the optimal sequence for the evaluation and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The optimal sequence begins with initial hemodynamic stabilization and pregnancy testing, followed by diagnostic physical and sonographic evaluation, inpatient admission for parenteral antibiotics, an observation period to assess treatment response, and finally a transition to oral outpatient antibiotics.
The correct clinical sequence follows the standard algorithmic approach to acute severe pelvic pain: resuscitate and rule out immediate life threats (pregnancy test, IV fluids), confirm the diagnosis and check for structural complications (pelvic exam, ultrasound), treat aggressively based on severity criteria (inpatient IV antibiotics), allow time for medical therapy to work before invasive measures (observe for 48-72 hours), and ensure complete eradication of infection (14-day total transition to oral therapy).

Step-by-Step Solution

1
Stabilize the patient and rule out ectopic pregnancy.
Intravenous fluids correct hypotension/tachycardia, and a negative beta-hCG rules out obstetric emergencies.
Life-threatening conditions must be addressed first in any acute abdominal presentation.
2
Diagnose the extent of the pelvic infection.
Physical examination confirms signs of pelvic inflammatory disease, and ultrasound assesses for complex adnexal masses.
Imaging dictates whether the patient has an uncomplicated infection or a tubo-ovarian abscess.
3
Initiate inpatient parenteral antimicrobial therapy.
Broad-spectrum intravenous antibiotics begin treating the polymicrobial infection.
Severe symptoms (vomiting, high fever) preclude the use of oral outpatient regimens.
4
Monitor clinical response over 48 to 72 hours.
The patient is evaluated for defervescence and reduction in abdominal pain.
Medical management is the first-line treatment even for complicated cases; failure to improve warrants surgical or image-guided intervention.
5
Discharge on a step-down oral regimen.
The patient completes a full 14-day antibiotic course.
Extended therapy is necessary to eradicate the infection completely and prevent long-term sequelae such as infertility.

Key Concept

Management Escalation in Complicated Pelvic Inflammatory Disease
Estimated Time:1m 30s
Question 275Question →

A 29-year-old primigravida at 40 weeks gestation is evaluated in the labor and delivery unit during the active phase of labor. Her pregnancy has been uncomplicated. Her cervix is 6 cm dilated, 90% effaced, and the fetal head is at -1 station. Uterine contractions are occurring every 3 to 4 minutes and are of moderate intensity. Thirty minutes after admission, the patient requests and receives continuous epidural anesthesia for pain relief.

Fifteen minutes later, the patient reports feeling lightheaded and nauseated. Her blood pressure is 82/45 mm Hg, and her heart rate is 105/min. The continuous fetal heart rate monitoring previously showed a baseline of 145/min with moderate variability and positive accelerations. The tracing now reveals minimal variability and gradual, symmetric decreases in the fetal heart rate from the baseline to a nadir of 125/min. The onset, nadir, and recovery of the decelerations occur after the beginning, peak, and end of the uterine contractions, respectively. These decelerations occur with more than 50% of contractions.

The nurse immediately turns the patient onto her left side and administers a bolus of intravenous lactated Ringer solution. Ten minutes later, the patient's blood pressure remains 86/48 mm Hg, and the fetal heart rate tracing is unchanged.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer ephedrine intravenously

Answer

The correct step is to administer ephedrine intravenously to correct the maternal hypotension and restore uteroplacental perfusion.
The correct answer addresses the root cause of the fetal distress. Epidural anesthesia causes a sympathetic blockade that can result in significant vasodilation and maternal hypotension. The resulting drop in blood pressure decreases perfusion to the uterus and placenta, presenting on the fetal monitor as late decelerations and decreased variability. Standard stepwise intrauterine resuscitation for maternal hypotension involves repositioning the patient to a left lateral decubitus position (relieving aortocaval compression) and giving an IV fluid bolus. Because these initial measures were insufficient in this patient, the immediate next step is to administer an intravenous vasopressor, such as ephedrine or phenylephrine, to mechanically constrict the vessels, correct the hypotension, and restore placental perfusion.

Step-by-Step Solution

1
Interpret the fetal heart rate tracing.
The gradual decreases with nadirs occurring after the peak of the contraction describe late decelerations, which indicate uteroplacental insufficiency.
Accurate interpretation of the fetal monitor is required to identify the underlying physiological stressor.
2
Identify the cause of the uteroplacental insufficiency.
The late decelerations coincide with a significant drop in maternal blood pressure shortly after epidural placement, indicating epidural-induced sympathetic blockade.
Identifying the etiology of late decelerations guides targeted intrauterine resuscitation.
3
Evaluate the response to initial interventions.
Left lateral decubitus positioning (to relieve aortocaval compression) and intravenous fluid boluses were attempted but failed to restore blood pressure.
Treatment must follow a stepwise escalation protocol.
4
Select the appropriate next pharmacological intervention.
Administration of an intravenous vasopressor (ephedrine or phenylephrine) is selected.
Vasopressors are required to reverse the persistent sympathetic blockade and restore blood flow to the placenta before considering invasive surgical delivery.

Key Concept

Epidural anesthesia can cause sympathetic blockade leading to maternal hypotension and secondary uteroplacental insufficiency (late decelerations). First-line treatment is left lateral repositioning and IV fluids; if these fail, an intravenous vasopressor (e.g., ephedrine or phenylephrine) is the next best step.
Estimated Time:2m 0s
Question 276Question →

A 16-year-old phenotypic female is brought to the gynecology clinic by her mother for evaluation of primary amenorrhea. She has never had a menstrual period. On physical examination, her blood pressure is 110/70 mm Hg, heart rate is 76/min, and BMI is 21 kg/m². Breast development is Tanner stage 4, but axillary and pubic hair are Tanner stage 1. Examination of the external genitalia reveals a normal-appearing clitoris and a shortened vaginal vault. Assuming each successive test or intervention directs the next step according to standard guidelines, arrange the following diagnostic and management steps in the correct chronological sequence to appropriately evaluate and treat this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Obtain a urine beta-hCG test, 2) Perform a pelvic ultrasonography, 3) Measure serum testosterone and obtain a karyotype, 4) Perform bilateral laparoscopic gonadectomy, and 5) Initiate estrogen replacement therapy.
The correct chronological sequence follows the standardized algorithmic approach to primary amenorrhea: always rule out pregnancy first, establish the presence or absence of a uterus via ultrasound, and then pursue specific endocrine and genetic testing based on the anatomical findings. Finally, the sequence culminates in the appropriate surgical and medical management of Complete Androgen Insensitivity Syndrome (CAIS).

Step-by-Step Solution

1
Order a urine beta-hCG test.
Rules out pregnancy.
Pregnancy is the most common cause of amenorrhea and must be excluded in all reproductive-age females before any further workup.
2
Perform pelvic ultrasonography.
Identifies the presence or absence of internal müllerian structures.
Guides the algorithm toward either an anatomical outflow tract issue or a genetic/endocrine etiology.
3
Measure serum testosterone and obtain a karyotype.
Confirms a 46,XY karyotype with male-range testosterone.
Differentiates Complete Androgen Insensitivity Syndrome from Müllerian agenesis in a patient with an absent uterus and normal breast development.
4
Perform bilateral laparoscopic gonadectomy.
Removes the cryptorchid testes.
Prevents malignant transformation (e.g., dysgerminoma), which is indicated after the completion of pubertal breast development.
5
Initiate estrogen replacement therapy.
Provides necessary hormonal support.
Maintains bone density and secondary sexual characteristics after the endogenous source of aromatized androgens is surgically removed.

Key Concept

Stepwise evaluation of primary amenorrhea and the definitive management of Complete Androgen Insensitivity Syndrome (CAIS).
Estimated Time:2m 0s
Question 277Question →

Match each clinical presentation of postpartum hemorrhage to its most likely underlying etiology.

Click a left item, then click its matching right item

Items

Heavy bleeding after delivery of a macrosomic neonate; examination reveals a soft, boggy uterus palpated above the umbilicus.
Continuous bright red bleeding following an operative vaginal delivery; examination reveals a firm, well-contracted uterus.
Severe abdominal pain and hemorrhage following vigorous umbilical cord traction; a round, red mass is visible at the vaginal introitus with an absent fundus on abdominal palpation.
Persistent bleeding postpartum despite a firm uterus; inspection of the delivered placenta reveals ragged edges and a missing cotyledon.

Matches

Show answer & explanation

Answer

The presentations match as follows: a soft/boggy uterus indicates uterine atony; continuous bleeding with a firm uterus indicates a genital tract laceration; a protruding vaginal mass with an absent abdominal fundus indicates uterine inversion; and a placenta with missing cotyledons indicates retained products of conception.
Postpartum hemorrhage (PPH) etiologies are classically categorized by the '4 Ts': Tone, Trauma, Tissue, and Thrombin.

Etiology (T)Classic FindingsCommon Risk Factors
Tone (Uterine atony)Soft, boggy, enlarged uterusFetal macrosomia, polyhydramnios, prolonged labor
Trauma (Laceration)Firm, contracted uterus with active bleedingOperative vaginal delivery, precipitous labor
Tissue (Retained placenta)Missing placental cotyledons, ragged edgesPlacenta accreta, prior uterine surgery
Thrombin (Coagulopathy)Oozing from IV sites, non-clotting bloodSevere preeclampsia, placental abruption, DIC
Additionally, uterine inversion is a rare but life-threatening complication (often categorized under Trauma) that presents with a visible vaginal mass and an absent uterine fundus on abdominal palpation, typically following excessive umbilical cord traction.

Step-by-Step Solution

1
Evaluate the uterine tone and position.
A soft, boggy uterus palpated above the umbilicus is identified.
This physical finding is diagnostic of uterine atony, confirming tone as the primary issue.
2
Assess for persistent bleeding in the presence of a firm, well-contracted uterus.
Continuous bleeding is noted despite adequate uterine tone.
This presentation points to a genital tract laceration, especially after an operative vaginal delivery.
3
Examine the vaginal introitus and abdominal fundus.
A protruding mass is observed with an absent fundus on abdominal palpation.
This specific combination of findings following excessive cord traction is indicative of uterine inversion.
4
Inspect the delivered placenta for completeness.
Missing cotyledons or ragged edges are identified on the placenta.
Missing placental tissue suggests retained products of conception as the ongoing source of bleeding.

Key Concept

Identifying the etiology of postpartum hemorrhage (PPH) based on physical examination findings.
Question 278Question →

During a busy shift on the labor and delivery unit, a 28-year-old primigravida at 39 weeks gestation is evaluated for labor progression. Her prenatal course was unremarkable. Recent routine laboratory studies showed a hemoglobin level of 10.5 g/dL10.5 \text{ g/dL} and a serum bicarbonate of 20 mEq/L20 \text{ mEq/L}.

She is currently receiving an oxytocin infusion for labor augmentation. Vital signs show a blood pressure of 118/76 mmHg118/76 \text{ mmHg}, heart rate of 88/min88/\text{min}, and a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}). Uterine contractions are occurring every 3 minutes and are strong to palpation.

Review of the continuous fetal monitor reveals a baseline heart rate of 130/min130/\text{min} with absent variability. Symmetrical, gradual decreases in the fetal heart rate to a nadir of 100/min100/\text{min} are noted, consistently beginning after the peak of each uterine contraction and resolving only after the contraction has ended. There are no spontaneous accelerations.

The nursing staff has already repositioned the patient to the left lateral decubitus position, administered an intravenous normal saline bolus, and discontinued the oxytocin infusion. Reassessment 20 minutes later shows no improvement in the fetal heart rate tracing. Cervical examination demonstrates dilation at 5 cm5 \text{ cm}, 90%90\% effacement, and the fetal vertex at a −1-1 station.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Cesarean delivery

Answer

Cesarean delivery
Cesarean delivery is the correct next step because the patient has a Category III fetal heart rate tracing (absent variability and recurrent late decelerations) that has not improved despite appropriate intrauterine resuscitative measures (repositioning, IV fluids, discontinuing oxytocin). Category III tracings are highly predictive of abnormal fetal acid-base status (fetal acidemia) and demand immediate delivery. Because the patient is only 5 cm dilated, an expedited vaginal delivery is not possible, making an emergent cesarean section the only appropriate intervention.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) tracing to determine its formal category.
The tracing shows absent variability accompanied by recurrent late decelerations, which strictly classifies it as a Category III tracing.
Accurate FHR categorization determines the urgency and specific type of obstetric intervention required.
2
Evaluate the patient's response to initial intrauterine resuscitative measures.
Conservative measures (maternal repositioning, IV fluids, and discontinuing oxytocin) have been actively utilized for 20 minutes without any improvement in the tracing.
Category III tracings are predictive of abnormal fetal acid-base status and require immediate resolution; if initial conservative measures fail, prompt surgical delivery is mandated.
3
Assess the feasibility of an immediate vaginal delivery.
The patient's cervix is only 5 cm dilated at a -1 station, meaning a vaginal delivery is not imminent.
Operative vaginal delivery (using forceps or a vacuum extractor) strictly requires a fully dilated cervix (10 cm) and an engaged fetal head.
4
Select the definitive management step.
Emergent cesarean delivery is chosen.
A persistent Category III tracing remote from vaginal delivery indicates severe impending fetal hypoxia-ischemia, making cesarean delivery the only safe option.

Key Concept

A Category III fetal heart rate tracing (characterized by absent variability with recurrent late decelerations, recurrent variable decelerations, or bradycardia) requires immediate intervention. If intrauterine resuscitative measures fail and vaginal delivery is not imminent, an emergent cesarean delivery must be performed.
Estimated Time:1m 30s
Question 279Question →

A 26-year-old woman presents to the clinic with a 7-month history of absent menstrual periods. She previously had regular 29-day cycles. She is sexually active and uses barrier contraception inconsistently. She denies headaches, visual changes, weight fluctuations, or galactorrhea. Her temperature is 37.0°C (98.6°F), blood pressure is 112/72 mm Hg, pulse is 72/min, and BMI is 23 kg/m². Pelvic examination shows normal female external genitalia and a normal-sized uterus. Assuming each successive test yields normal or negative results, arrange the following diagnostic steps in the most appropriate chronological sequence for evaluating this patient's secondary amenorrhea.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Pregnancy test, followed by Prolactin/TSH, followed by Progestin challenge test, followed by FSH measurement.
The correct chronological approach to secondary amenorrhea minimizes unnecessary testing by ruling out the most common causes first. Pregnancy is the most frequent cause and requires a beta-hCG test. Once excluded, TSH and prolactin are measured to rule out thyroid disease and prolactinomas. If these are normal, a progestin challenge is given to confirm adequate endogenous estrogen and a patent outflow tract (withdrawal bleeding occurs). If no bleeding occurs, FSH is measured to distinguish ovarian failure from hypothalamic-pituitary dysfunction.

Step-by-Step Solution

1
Rule out pregnancy
Urine beta-hCG test
Pregnancy must always be excluded first in any premenopausal woman presenting with amenorrhea.
2
Screen for common systemic endocrine disorders
Serum prolactin and TSH testing
Thyroid dysfunction and hyperprolactinemia can disrupt the hypothalamic-pituitary-ovarian axis and are easily identified.
3
Assess estrogen status
Progestin challenge test
Evaluates whether the ovaries are producing enough estrogen to prime the endometrium for a withdrawal bleed.
4
Localize the defect if progestin challenge is negative
Serum FSH testing
Differentiates between hypergonadotropic hypogonadism (ovarian failure) and hypogonadotropic hypogonadism (central causes).

Key Concept

The standard step-wise diagnostic algorithm for secondary amenorrhea begins with excluding pregnancy, followed by identifying common endocrine abnormalities (thyroid or prolactin disorders), assessing estrogen status, and finally differentiating ovarian from central etiologies.
Question 280Question →

Match each specific gynecologic ovarian neoplasm with its most characteristic serum tumor marker used for clinical diagnosis and disease monitoring.

Click a left item, then click its matching right item

Items

Dysgerminoma
Yolk sac (endodermal sinus) tumor
Granulosa cell tumor
Choriocarcinoma
High-grade serous ovarian carcinoma

Matches

Show answer & explanation

Answer

Dysgerminoma matches with LDH. Yolk sac tumor matches with AFP. Granulosa cell tumor matches with inhibin. Choriocarcinoma matches with beta-hCG. High-grade serous ovarian carcinoma matches with CA-125.
Each histologic subtype of ovarian cancer produces highly specific biomarkers. Accurately pairing the neoplasm with its biochemical marker is critical for initial diagnosis, evaluating response to chemotherapy, and early detection of disease relapse.

Step-by-Step Solution

1
Determine the broad histologic category for each ovarian tumor.
Identify if the tumor is epithelial (serous), sex cord-stromal (granulosa), or germ cell (dysgerminoma, yolk sac, choriocarcinoma).
Tumor lineage dictates the biochemical markers secreted into the bloodstream.
2
Correlate germ cell tumors with their specific embryologic markers.
Dysgerminomas typically secrete LDH, Yolk sac tumors secrete AFP, and Choriocarcinomas secrete beta-hCG.
Germ cell tumors replicate structures of early human development. For example, the yolk sac produces AFP similar to the fetal liver, and trophoblasts produce hCG similar to the placenta.
3
Correlate non-germ cell tumors with their characteristic markers.
Granulosa cell tumors secrete inhibin. Epithelial serous carcinomas express CA-125.
Granulosa cells physiologically produce inhibin. CA-125 is a glycoprotein heavily expressed by derivatives of the coelomic epithelium.

Key Concept

Gynecologic Oncology Tumor Markers
Estimated Time:1m 0s
PreviousPage 14 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 14 | Examkin